Business

VITL case: investors face May 26, 2026 lead-plaintiff deadline

Vital Farms (NASDAQ: VITL) investors who bought or acquired shares between May 8, 2025 and February 26, 2026 have a date circled on their calendars: May 26, 2026.

Faruqi & Faruqi, LLP says it is investigating potential claims against Vital Farms, Inc. and is reminding investors of the deadline to seek the role of lead plaintiff in a federal securities class action already filed in connection with the company. Securities Litigation Partner James (Josh) Wilson encouraged affected investors to contact him directly to discuss options, and listed phone numbers at 877-247-4292 or 212-983-9330 (Ext. 1310).

The legal pitch, laid out in a press-style notice, centers on allegations that Vital Farms and its executives violated federal securities laws through false and/or misleading statements or by failing to disclose certain issues. According to the complaint’s allegations as described, the ERP implementation was framed earlier as important, with “management and key crew members” investing “significant” time and attention to the roll-out. But by the time the 3Q 2025 10-Q was filed, the ERP was reportedly already implemented, with “slowed down production” linked to that implementation.

From there, the argument gets more pointed. The notice claims that even if the slowdown happened in the first two weeks of the fourth quarter of 2025, the risk disclosure concerning the ERP implementation was deficient—because, as the allegation goes, the delay was more than a hypothetical at that point. It also says Defendants, who allegedly had never previously warned investors that production would slow down from implementing the ERP, later alleged the slowdown was “always part of our plan.”

There’s a specific description of how guidance and messaging allegedly played out. Instead of admitting the impact of the slower production on Vital Farms’ operations, the notice says Defendants misled investors by stating “the business has quickly bounced back and we are now operating at pre go live shipment levels.” It further alleges that Defendants said the slowdown “had no impact on our guidance for the full year,” and even increased 2025 guidance from $770,000,000 to $775,000,000.

The company’s exposure, in this telling, isn’t only about quarterly numbers. The notice claims that as a result of delayed shipments and/or production, Vital Farms would lose important retail shelf space, which would negatively impact its business and operations. The timeline also references market movement: on February 26, 2026, Misryoum newsroom reported an article entitled “Vital Farms (NASDAQ: VITL) Shares Gap Down Following Weak Earnings,” stating the stock price “gapped down before the market opened on Thursday after the company announced weaker than expected quarterly earnings.” The notice adds that Vital Farms stock fell 10.8% on February 26, 2026.

If investors want to participate, the mechanism is fairly straightforward, at least in description. The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members, directing and overseeing the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member, and—important—your ability to share in a recovery is not affected by the decision to serve as lead plaintiff or not. Somewhere between the legal structure and the deadline, it’s easy to lose the plot, but it still lands on May 26, 2026. (I swear the printer in the office made a little buzzing sound when the page about “lead plaintiff” came back—of all things.)

Faruqi & Faruqi also encourages whistleblowers, former employees, shareholders, and others with information about Vital Farms’ conduct to contact the firm. To learn more about the Vital Farms class action, investors are directed to go to www.faruqilaw.com/VITL or call Josh Wilson at 877-247-4292 or 212-983-9330 (Ext. 1310). Attorney Advertising is noted in the material, and it includes standard language that prior results don’t guarantee or predict a similar outcome.

Leave a Reply

Your email address will not be published. Required fields are marked *

Are you human? Please solve:Captcha